Clinical Trials Logo

Clinical Trial Summary

In this randomized clinical trial, patients with undergoing open heart valve surgery will be enrolled into the study. Participants will be divided into two groups based on the priming solution type. The first group will receive hydroxyethyl starch (HES) 130/0.4 additive to ringer lactate (RL) and the second group will be given only RL as priming solution. All patients will be observed closely during postoperative days. Through follow up, bleeding/coagulopathy, renal function, hepatic function, and cerebral oxygenation will be recorded in both groups.


Clinical Trial Description

Cardiopulmonary bypass (CPB) pump is a device for circulating blood in the body while the heart is undergone surgery. For providing circulating volume in the body we need to add about 1.5 to 2 lit fluids as priming solution in the CPB pump. Some fluids mainly included crystalloids, colloids, starch, and gelatin in an only fluid or in a combined formula. During CPB time, the blood dilution is caused by adding prime solution into the circulating volume, and consequently it decreases blood viscosity. Moreover, in addition to a decrease in hematocrit level, coagulation factors and plasma proteins can dramatically decreased. These processes may lead to bleeding events and tissue hypoperfusion and organ damages. To decrease complications, some modalities such as adding colloids to crystalloids have been implemented. On the other hand, any regimen for priming solution has its shortcomings need to be considered based on patient condition and surgical issue. In this double blinded randomized clinical trial study, we aimed to compare the the effects of six percent HES 130/0.4 and RL as priming solutions on coagulation factors, renal function, hepatic function, and cerebral oxygenation in patients undergoing open heart valve surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05223361
Study type Interventional
Source Rajaie Cardiovascular Medical and Research Center
Contact
Status Completed
Phase Phase 3
Start date April 2016
Completion date November 30, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02865798 - China Senile Valvular Heart Disease Cohort Study N/A
Completed NCT02249000 - BIOVALVE - I / II Clincial Investigation N/A
Completed NCT02297334 - Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery N/A
Completed NCT01591018 - SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry Phase 3
Completed NCT01428947 - Does Coronary Angiography Cause Cognitive Dysfunction? N/A
Recruiting NCT01231776 - Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary Bypass N/A
Terminated NCT01116037 - ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study N/A
Completed NCT00371891 - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS) Phase 4
Terminated NCT03632967 - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System N/A
Recruiting NCT05728047 - Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
Not yet recruiting NCT05539261 - Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery
Completed NCT05479968 - Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery
Completed NCT03527381 - Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery Phase 1/Phase 2
Completed NCT03664102 - Automated Fastener Device Versus Manually Tied Knot in MiAVR
Recruiting NCT06084091 - Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
Completed NCT05836467 - Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?
Recruiting NCT05933083 - MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation N/A
Recruiting NCT04445012 - Cardiovascular Acoustics and an Intelligent Stethoscope
Active, not recruiting NCT02732691 - JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study N/A
Completed NCT02981953 - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System N/A